title: First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta(2)-microglobulin in hemodialysis.
authors.affiliation: Renal Research Institute, New York, NY, USA. cronco@goldnet.it
authors.forename: C
authors.initials: C
authors.lastname: Ronco
authors.forename: A
authors.initials: A
authors.lastname: Brendolan
authors.forename: J F
authors.initials: JF
authors.lastname: Winchester
authors.forename: E
authors.initials: E
authors.lastname: Golds
authors.forename: J
authors.initials: J
authors.lastname: Clemmer
authors.forename: H D
authors.initials: HD
authors.lastname: Polaschegg
authors.forename: T E
authors.initials: TE
authors.lastname: Muller
authors.lastname: La Greca G
authors.forename: N W
authors.initials: NW
authors.lastname: Levin
mesh_terms: D000327:Adsorption; D000328:Adult; D000686:Amyloidosis / Q000209:etiology / Q000517:prevention & control*; D000925:Anticoagulants / Q000008:administration & dosage; D001772:Blood Cell Count; D001780:Blood Coagulation Tests; D020099:Coated Materials, Biocompatible; D004867:Equipment Design; D006464:Hemoperfusion / Q000295:instrumentation*; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D007262:Infusions, Intravenous; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications / Q000628:therapy; D008297:Male; D008863:Microspheres; D008875:Middle Aged; D011108:Polymers; D011137:Polystyrenes; D011205:Povidone; D006435:Renal Dialysis / Q000009:adverse effects / Q000295:instrumentation*; D012709:Serum Albumin / Q000032:analysis; D016060:Sorption Detoxification / Q000295:instrumentation*; D013450:Sulfones; D014511:Uremia / Q000097:blood / Q000150:complications / Q000628:therapy*; D001613:beta 2-Microglobulin / Q000032:analysis*
chemical_list: D000925:Anticoagulants; D020099:Coated Materials, Biocompatible; D011108:Polymers; D011137:Polystyrenes; D012709:Serum Albumin; D013450:Sulfones; D001613:beta 2-Microglobulin; C017662:polysulfone P 1700; D006493:Heparin; D011205:Povidone